We Offer Sublocade Treatment

Sublocade is a monthly injection of buprenorphine used to treat opioid use disorder.

Text or call us for a free consultation today.

GET PREQUALIFIED TODAY!!. We will verify your benefits and reach out to you within minutes.
Name of Individual*
First Last
Date Of Birth*
MM slash DD slash YYYY
Insurance Company on Card*
Insurance Policy #*

Listed on insurance card. This information is 100% HIPAA protected.
Your Phone Number*
Email
Comments (Optional)
Insurance Card Photo (Optional)
Max. file size: 50 MB.

How Does Sublocade Work?

SUBLOCADE continuously releases buprenorphine all month with no real daily ups and downs.

The SUBLOCADE (buprenorphine extended-release) injection, for subcutaneous use (CIII) is indicated for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a buprenorphine-containing product, followed by dose adjustment for a minimum of 7 days.

Sublocade Clinical Study

This graph shows that the treatment success rate was 28% among patients in the 300/100 mg group and 29% in the 300/300 mg group, vs 2% in the placebo group. Treatment success is defined at ≥80% illicit opioid-free weeks. Patients treated with once-monthly SUBLOCADE plus counseling were 14 times more likely to have treatment success vs placebo.

Treatment Success

Patients with ≥80% of urine samples negative for illicit opioids combined with self-reports negative for illicit opioid use between Week 5 and Week 24

Sublocade Studies

In clinical studies, SUBLOCADE blocked the subjective rewarding effects of illicit opioids. After the first injection, patients' median drug-liking VAS scores trended toward 0.

Focus on Mental Health

SUBLOCADE helped patients overcome the drivers of addiction, which may also have helped them focus on other aspects of their recovery

“New Start helped make me feel comfortable and safe during the detox process. The medications made the process easy.”

Anonymous Client Review